Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01423786
Other study ID # IRB11-00446
Secondary ID 277711
Status Terminated
Phase N/A
First received
Last updated
Start date August 2011
Est. completion date July 16, 2014

Study information

Verified date August 2011
Source Nationwide Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective trial for children with the diagnosis of mild acute pancreatitis admitted to the hospital for continued management. Patients will be enrolled in the study within 24 hours of admission/diagnosis and will be allowed an oral diet once enrolled. Demographic, laboratory and imaging data done as standard of care will be collected and additional blood work will be sent as part of the study. Patients will be followed prospectively with regards to tolerance to oral nutrition, pain, length of stay and complications. The hypothesis is that patients that are able to tolerate early oral nutrition will have shorter length of stays and will be similar in terms of pain score ratings, readmission rates, complications and the need for invasive supplemental nutrition. Also patients that are able to tolerate early oral nutrition will have less significant elevation of biochemical markers of pancreatitis severity when compared to patients that do not tolerate early oral nutrition and historical controls.


Recruitment information / eligibility

Status Terminated
Enrollment 34
Est. completion date July 16, 2014
Est. primary completion date July 16, 2014
Accepts healthy volunteers No
Gender All
Age group 2 Years to 21 Years
Eligibility Inclusion Criteria:

- Diagnosis of acute pancreatitis

- Enroll within 24 hours of diagnosis

- At least 50% of baseline diet must be taken orally

Exclusion Criteria:

- Evidence of severe pancreatitis

- Diagnosis of chronic pancreatitis

- Patients unable to communicate pain or a desire to eat/drink

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Early Oral Nutrition
Once enrolled in the study, patients will be allowed a oral diet that is low in fat.

Locations

Country Name City State
United States Nationwide Children's Hospital Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Nationwide Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tolerance of Oral Nutrition The time it takes for the patient to tolerate at least 50% of his/her goal oral calories while maintaining hydration as assessed by urine ouput or fluid intake 1 week
Secondary Length of Stay The length of time between admission for acute pancreatitis and discharge. 1 week